Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aimei Health Technology (AFJK) EBITDA (2024 - 2025)

Aimei Health Technology (AFJK) has 2 years of EBITDA data on record, last reported at -$130152.0 in Q3 2025.

  • On a quarterly basis, EBITDA rose 34.93% to -$130152.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$987191.0, a N/A change, with the full-year FY2024 number at -$1.1 million, down 3641.47% from a year prior.
  • EBITDA reached -$130152.0 in Q3 2025 per AFJK's latest filing, down from -$41604.0 in the prior quarter.
  • Over the last five years, EBITDA for AFJK hit a ceiling of -$41604.0 in Q2 2025 and a floor of -$413414.0 in Q1 2025.